These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5532152)

  • 1. [Clinical study of a new hypoglycemic sulfonamide: glibenclamide].
    Guinet P; Tourniaire J; Ollier C
    Rev Lyon Med; 1970 Oct; 19(16):655-64. PubMed ID: 5532152
    [No Abstract]   [Full Text] [Related]  

  • 2. Diurnal blood sugar levels and clinical experience during glibenclamide therapy.
    O'Sullivan DJ
    Postgrad Med J; 1970 Dec; ():Suppl:46-9. PubMed ID: 5533296
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
    Gurling KJ
    Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-3 passim. PubMed ID: 4997365
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical use of glibenclamide in diabetes mellitus.
    Luntz GR
    Postgrad Med J; 1970 Dec; ():Suppl:84-7. PubMed ID: 5533303
    [No Abstract]   [Full Text] [Related]  

  • 6. Twenty-four-hour urinary glucose levels during tolbutamide and glibenclamide therapy.
    Cohen H; Clyne JR
    Postgrad Med J; 1970 Dec; ():Suppl:50-2. PubMed ID: 5533297
    [No Abstract]   [Full Text] [Related]  

  • 7. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of a new hypoglycemic sulfamide: glibenclamide or HB 419].
    Plauchu M
    Lyon Med; 1969 Nov; 222(40):809-16. PubMed ID: 5383402
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical treatment results with glycodiazine].
    Fein C; Stemann G; Nusser E
    Med Welt; 1968 Sep; 36():1921-6. PubMed ID: 4887074
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-therapeutic experiences with the new hypoglycemic sulfanylurea, glibenclamide].
    Arena D; Santeusanio F; Puxeddu A; De Ciuceis P; Migliorini E; Siracusa A; Brunetti P
    Clin Ter; 1970 Mar; 52(6):509-23. PubMed ID: 5452996
    [No Abstract]   [Full Text] [Related]  

  • 13. Circadian variation of glucose, insulin and free fatty acids during the long-term use of oral hypoglycaemic agents in diabetes mellitus with special reference to glibenclamide.
    Hadden DR; Bhatia SK; Rigas A; Weaver JA; Montgomery DA
    Postgrad Med J; 1970 Dec; ():Suppl:53-7. PubMed ID: 5533298
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of a hypoglycemic sulfonamide: 1324 AN (gludiase) in treatment of diabetes].
    Warembourg H; Jaillard J
    Lille Med; 1968 Dec; 13(10):Suppl 7:1065+. PubMed ID: 5720293
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature.
    Balodimos MC; Marble A
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):6-12. PubMed ID: 4992570
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():871-8. PubMed ID: 10091160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma insulin and metabolic study on diabetes treated with glibenclamide.
    Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlinson RW; Woodroffe F
    Postgrad Med J; 1970 Dec; ():Suppl:36-41. PubMed ID: 5533294
    [No Abstract]   [Full Text] [Related]  

  • 18. [A report on clinical trials with the oral antidiabetic SH 717 (Redul) of the Bayer-Schering firm].
    Leubner H
    Wien Klin Wochenschr; 1965 Dec; 77(51):1007-9. PubMed ID: 5331453
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes in the elderly. Treatment goals depend on age-related issues.
    McCarthy R
    Adv Nurse Pract; 2001 Jul; 9(7):28-32, 87. PubMed ID: 12420450
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoglycaemic action of oxytetracycline. A preliminary study.
    Sen S; Mukerjee AB
    J Indian Med Assoc; 1969 Apr; 52(8):366-9. PubMed ID: 5824581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.